InvestorsHub Logo
Followers 1
Posts 1178
Boards Moderated 0
Alias Born 02/01/2013

Re: None

Saturday, 07/14/2018 12:22:25 PM

Saturday, July 14, 2018 12:22:25 PM

Post# of 108192
Replimune Readies $100 Million U.S. IPO, same technology as Advaxis.

The firm pioneered the first FDA-approved oncolytic immunotherapy - a neoantigen vaccine specific for patients' tumors. This is a new class of cancer treatment which uses the ability of certain viruses to selectively replicate and kill tumors.

https://seekingalpha.com/article/4186434-replimune-readies-100-million-u-s-ipo
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News